4.5 Article

Safety of 5-hydroxy-L-tryptophan

期刊

TOXICOLOGY LETTERS
卷 150, 期 1, 页码 111-122

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2003.12.070

关键词

5-hydroxy-L-tryptophan; 5-HTP 5-L-HTP; 5-OH-Trp; L-tryptophan; LT; L-Trp; 5-HT; eosinophilia-myalgia syndrome; EMS; eosinophilia-myalgia syndrorne-related disorder EMS-related disorder; peak X; tryptophan-4,5-dione; L-Trp-4,5D; dietary supplement

向作者/读者索取更多资源

5-Hydroxy-(L)-tryptophan (5-HTP) is the immediate precursor in the biosynthesis of 5-hydroxy-tryptamine (5-HT; serotonin) from the essential amino acid (L)-tryptophan ((L)-Trp). The use Of (L)-Trp as a dietary supplement was discontinued in 1989 due to an outbreak of eosinophilia-myalgia syndrome (EMS) that was traced to a contaminated synthetic (L)-Trp from a single manufacturer. 5-HTP has since become a popular dietary supplement in lieu of the removal Of (L)-Trp from the market. Because of its chemical and biochemical relationship to (L)-Trp, 5-HTP has been under vigilance by consumers, industry, academia and government for its safety. However, no definitive cases of toxicity have emerged despite the worldwide usage of 5-HTP for last 20 years, with the possible exception of one unresolved case of a Canadian woman. Extensive analyses of several sources of 5-HTP have shown no toxic contaminants similar to those associated with (L)-Trp, nor the presence of any other significant impurities. A minor chromatographic peak (peak X) reported in some 5-HTP samples lacks credibility due to chromatographic artifacts and infinitesimal concentrations, and has raised undue speculations concerning its chemistry and toxicity. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据